Related Experiment Video
Updated: Aug 11, 2026

Methods for the Modulation and Analysis of NF-κB-dependent Adult Neurogenesis
Published on: February 13, 2014
TGFbeta1 regulates the inflammatory response during chronic neurodegeneration
Delphine Boche1, Colm Cunningham, Fabian Docagne
1CNS Inflammation Group, Southampton Neurosciences Group, School of Biological Sciences, University of Southampton, Southampton, SO16 7PX Hampshire, UK. D.Boche@soton.ac.uk
Abstract:
The ME7 model of murine prion disease shows an atypical inflammatory response characterized by morphologically activated microglia and an anti-inflammatory cytokine profile with a marked expression of TGFbeta1. The investigation of the role of TGFbeta1 during a time course disease shows that its expression is correlated with (i) the onset of behavioral abnormalities, (ii) increased activated microglia, (iii) thickening of the basement membrane, and (iv) is associated with increased PrP(sc) deposition. Increasing TGFbeta1 using an adenoviral vector has no significant impact on prion-associated behavioral impairments or on neuropathology. In contrast, inhibition of TGFbeta1 activity using an adenovirus expressing decorin induces severe cerebral inflammation, expression of inducible nitric oxide synthase and acute neuronal death in prion-diseased animals only. These data suggest that TGFbeta1 plays a critical role in the downregulation of microglial responses minimizing brain inflammation and thus avoiding exacerbation of brain damage.
Insights
Transforming growth factor-beta1 (TGFbeta1) limits brain inflammation in prion disease models. Inhibiting TGFbeta1 exacerbates neuroinflammation and neuronal death, highlighting its protective role in prion-related brain damage.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Murine prion disease (ME7 model) exhibits atypical neuroinflammation with activated microglia and elevated TGFbeta1.
- TGFbeta1 expression correlates with disease progression, including behavioral changes, microglial activation, basement membrane thickening, and PrP(sc) deposition.
Purpose of the Study:
- To investigate the role of TGFbeta1 in prion disease pathogenesis.
- To determine if modulating TGFbeta1 levels impacts neuroinflammation and neuropathology.
Main Methods:
- Time-course analysis of TGFbeta1 expression in the ME7 prion disease model.
- Adenoviral vector-mediated manipulation of TGFbeta1 levels (increase and inhibition via decorin).
- Assessment of behavioral abnormalities, microglial activation, basement membrane, PrP(sc) deposition, inducible nitric oxide synthase (iNOS), and neuronal death.
Main Results:
- Increased TGFbeta1 did not significantly alter behavioral impairments or neuropathology.
- Inhibition of TGFbeta1 activity led to severe cerebral inflammation, iNOS expression, and acute neuronal death specifically in prion-diseased animals.
- TGFbeta1 appears to downregulate microglial responses, thereby minimizing brain inflammation.
Conclusions:
- TGFbeta1 plays a critical neuroprotective role in prion disease.
- TGFbeta1 limits microglial activation and subsequent neuroinflammation, preventing exacerbated brain damage.
- Targeting TGFbeta1 may have therapeutic implications for prion diseases.
Related Concept Videos
Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
TGF - β Signaling Pathway
Chronic Inflammation: Introduction
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Gut-Brain Axis
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
